Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. [electronic resource]
- Blood Apr 2001
- 2390-400 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0006-4971
10.1182/blood.v97.8.2390 doi
Active Transport, Cell Nucleus Adult Cyclosporine--pharmacology DNA-Binding Proteins--physiology Enzyme Inhibitors--pharmacology Gene Expression Regulation--drug effects HIV Long Terminal Repeat--physiology HIV-1--physiology Humans Immunosuppressive Agents--pharmacology Interleukin-1--genetics Interleukin-2--pharmacology Intracellular Signaling Peptides and Proteins Ionomycin--pharmacology Jurkat Cells--drug effects Lymphocyte Specific Protein Tyrosine Kinase p56(lck)--deficiency NF-kappa B--physiology NFATC Transcription Factors Nuclear Proteins Organometallic Compounds--pharmacology Phytohemagglutinins--pharmacology Promoter Regions, Genetic--drug effects Protein Transport Protein Tyrosine Phosphatase, Non-Receptor Type 6 Protein Tyrosine Phosphatases--antagonists & inhibitors Protein-Tyrosine Kinases--physiology Receptors, Antigen, T-Cell--physiology Recombinant Fusion Proteins--biosynthesis Recombinant Proteins--pharmacology Tacrolimus--pharmacology Tetradecanoylphorbol Acetate--pharmacology Transcription Factors--physiology Transcription, Genetic--drug effects ZAP-70 Protein-Tyrosine Kinase